Dr. Rafael Gonzalez, MD

Dr. Gonzalez practices at Las Mercedes Medical Centers in Miami, Florida.

Dr. Gonzalez's NPI, 1487608840, was assigned on May 20, 2006. Dr. Gonzalez graduated from Instituto Superior de Ciencias Medicinas de Villa Clara in 1985. Dr. Gonzalez holds Florida license ME89042.

Dr. Gonzalez's primary practice is Las Mercedes Medical Centers, at 1479 Nw 27th Ave, Miami, FL 33125-2133. The practice phone is (305) 633-3776.

Dr. Gonzalez's primary practice is Las Mercedes Medical Centers in Miami, Florida. The medical group on file is Las Mercedes Medical Centers. Dmand AI also links Dr. Gonzalez to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gonzalez practices, 2 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Gonzalez's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dr. Gonzalez is licensed in Florida.

Dmand AI lists acid reflux, acute skin infection, aneurysm, ankle or foot injury, aortic atherosclerois, arthritis, asthma and atrial fibrillation and flutter among the conditions Dr. Gonzalez treats.

CMS data shows 916 Medicare services from Dr. Gonzalez across 7 procedure codes in 2024, for 391 Medicare patients. Medicare paid $84,875 for them. Every service was in an office.

CMS counts 391 Medicare patients who saw Dr. Gonzalez in 2024. The largest group is 65 to 74, with 206 patients. 63% of them have high blood pressure, and 63% have high cholesterol. 94% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gonzalez's median patient age at 73, with 65% women.

In 2024, Dr. Gonzalez wrote 29,258 Medicare Part D claims for 617 patients. 93% of them were for generic drugs. CMS names the drug for 28,558 of them, across 205 drugs with 11 or more claims each, at $781,384 in total drug cost. In 2023, CMS named 32,339 claims across 220 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gonzalez for performance year 2024, reported individually. Dr. Gonzalez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Gonzalez, published from 2015 to 2020. 2015 was the busiest year, with 2. The most frequent topics are Abdomen, Lung and Perioperative Care.

Dmand AI links Dr. Gonzalez to 1 clinical trial. Conditions studied include COVID-19 and Pneumonia, Viral. Open Payments lists research payments to Dr. Gonzalez that name 1 trial.

CMS Open Payments shows 9 general payments to Dr. Gonzalez from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Next Science LLC paid the most, $118. It also lists 44 research payments totaling $726,843 from 2018 to 2024, naming 1 clinical trial.

Dr. Gonzalez graduated from Instituto Superior de Ciencias Medicinas de Villa Clara in 1985.

Dr. Gonzalez is in network with 11 carriers, including United Healthcare, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.